Article
Substitution of a mutant alpha2a-adrenergic receptor via "hit and run" gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo.
Proceedings of the National Academy of Sciences of the United States of America - 2 Sept 1997
Lakhlani P P, MacMillan L B, Guo T Z, McCool B A, Lovinger D M, Maze M, Limbird L E
Abstract excerpt
Norepinephrine contributes to antinociceptive, sedative, and sympatholytic responses in vivo, and alpha2 adrenergic receptor (alpha2AR) agonists are used clinically to mimic these effects. Lack of subtype-specific agonists has prevented elucidation of the role that each alpha2AR subtype (alpha2A, alpha2B, and alpha2C) plays in these central effects. Here we demonstrate that alpha2AR agonist-elicited sedative,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.